To include your compound in the COVID-19 Resource Center, submit it here.

EntreMed cancer, autoimmune news

EntreMed restructured and reduced headcount by 30 (59%) to 21 to lower costs. The company will focus on

Read the full 180 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE